Jacobi Capital Management’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$539K Buy
1,356
+783
+137% +$342K 0.03% 437
2026
Q1
$264K Buy
573
+53
+10% +$26.8K 0.01% 559
2025
Q4
$295K Hold
520
0.02% 531
2025
Q3
$233K Buy
520
+8
+2% +$3.84K 0.01% 564
2025
Q2
$278K Buy
+512
New +$268K 0.02% 518
2021
Q4
Sell
-234
Closed -$78K 846
2021
Q3
$78K Hold
234
0.01% 557
2021
Q2
$72K Hold
234
0.01% 545
2021
Q1
$58K Hold
234
0.01% 547
2020
Q4
$64K Hold
234
0.01% 488
2020
Q3
$55K Hold
234
0.01% 477
2020
Q2
$44K Sell
234
-30
-11% -$5.38K 0.01% 500
2020
Q1
$44K Buy
264
+39
+17% +$7.14K 0.01% 440
2019
Q4
$44K Hold
225
0.01% 488
2019
Q3
$40K Hold
225
0.01% 486
2019
Q2
$39K Hold
225
0.01% 487
2019
Q1
$43K Hold
225
0.01% 435
2018
Q4
$36K Hold
225
0.01% 430
2018
Q3
$43K Hold
225
0.01% 441
2018
Q2
$36K Hold
225
0.01% 467
2018
Q1
$30K Hold
225
0.01% 478
2017
Q4
$29K Sell
225
-450
-67% -$56.3K 0.01% 472
2017
Q3
$27K Buy
+675
New +$73.5K 0.01% 444

Other funds holding ISRG

Jacobi Capital Management's ISRG Position: Q2 2026 in Review

Jacobi Capital Management increased its Intuitive Surgical (ISRG) stake by 137% in Q2 2026, buying an estimated $342K and bringing the position to 1,356 shares worth $539K. The position accounts for 0.03% of the portfolio, ranked #437.

Jacobi Capital Management first reported a position in ISRG in Q3 2017 and has held it in 22 quarters since. 2,254 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Jacobi Capital Management held 1,356 shares of Intuitive Surgical worth $539K as of Q2 2026.
  • Jacobi Capital Management bought 783 Intuitive Surgical shares in Q2 2026, an estimated $342K.
  • Intuitive Surgical made up 0.03% of Jacobi Capital Management's portfolio in Q2 2026, its #437 holding.
  • Jacobi Capital Management first reported a position in Intuitive Surgical in Q3 2017 and has held it in 22 quarters since.
  • 2,254 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Jacobi Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.